PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
This Quarter Return
+4.57%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$48.2M
AUM Growth
+$48.2M
(-11%)
Cap. Flow
-$8.39M
Cap. Flow
% of AUM
-17.38%
Top 10 Holdings %
Top 10 Hldgs %
35.84%
Holding
104
New
20
Increased
18
Reduced
21
Closed
26
Top Buys
| 1 |
AET
Aetna Inc
AET
|
$1.91M |
| 2 |
Biogen
BIIB
|
$1.73M |
| 3 |
Baxter International
BAX
|
$1.26M |
| 4 |
McKesson
MCK
|
$1.11M |
| 5 |
UnitedHealth
UNH
|
$1.09M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$2.22M |
| 2 |
Bristol-Myers Squibb
BMY
|
$1.88M |
| 3 |
AGN
Allergan plc
AGN
|
$1.83M |
| 4 |
Gilead Sciences
GILD
|
$1.6M |
| 5 |
Apple
AAPL
|
$1.58M |
Sector Composition
| 1 | Healthcare | 51.78% |
| 2 | Technology | 10.82% |
| 3 | Communication Services | 5.42% |
| 4 | Financials | 5.33% |
| 5 | Energy | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Antero Resources
AR
$9.86B
| $770K | 1.26% |
+29,620
| New | +$770K |
|
27
Herbalife
HLF
$1.01B
| $765K | 1.25% |
13,069
+4,616
| +55% | +$270K |
|
28
Universal Health Services
UHS
$11.6B
| $685K | 1.12% |
5,105
-6,082
| -54% | -$816K |
|
29
Halliburton
HAL
$19.4B
| $683K | 1.12% |
+15,080
| New | +$683K |
|
30
Puma Biotechnology
PBYI
$254M
| $677K | 1.11% |
+22,740
| New | +$677K |
|
|
31
Bristol-Myers Squibb
BMY
$96B
| $669K | 1.09% |
9,099
-25,588
| -74% | -$1.88M |
|
32
Palo Alto Networks
PANW
$127B
| $666K | 1.09% |
5,427
-3,174
| -37% | -$390K |
|
33
Hologic
HOLX
$14.9B
| $651K | 1.06% |
18,827
+9,633
| +105% | +$333K |
|
34
Devon Energy
DVN
$22.9B
| $462K | 0.76% |
+12,741
| New | +$462K |
|
35
Alibaba
BABA
$322B
| $444K | 0.73% |
5,585
+2,816
| +102% | +$224K |
|
|
CLVS
36
DELISTED
Clovis Oncology, Inc.
CLVS
| $431K | 0.71% |
31,406
-539
| -2% | -$7.4K |
|
|
BPMC
37
DELISTED
Blueprint Medicines
BPMC
| $406K | 0.66% |
20,049
+1,261
| +7% | +$25.5K |
|
|
ELGX
38
DELISTED
Endologix Inc
ELGX
| $396K | 0.65% |
+31,800
| New | +$396K |
|
39
Accuray
ARAY
$157M
| $377K | 0.62% |
72,684
-6,199
| -8% | -$32.2K |
|
40
Tenet Healthcare
THC
$16.3B
| $363K | 0.59% |
+13,136
| New | +$363K |
|
41
Vulcan Materials
VMC
$38.5B
| $357K | 0.58% |
2,964
-5,566
| -65% | -$670K |
|
|
ZLTQ
42
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $347K | 0.57% |
12,713
-7,261
| -36% | -$198K |
|
|
GBT
43
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $338K | 0.55% |
20,383
+3,535
| +21% | +$58.6K |
|
44
Molina Healthcare
MOH
$9.8B
| $322K | 0.53% |
+6,445
| New | +$322K |
|
|
RICE
45
DELISTED
Rice Energy Inc.
RICE
| $322K | 0.53% |
+14,613
| New | +$322K |
|
46
Visa
V
$683B
| $295K | 0.48% |
+3,982
| New | +$295K |
|
47
Vertex Pharmaceuticals
VRTX
$100B
| $295K | 0.48% |
+3,425
| New | +$295K |
|
48
Voyager Therapeutics
VYGR
$186M
| $288K | 0.47% |
26,187
+11,852
| +83% | +$130K |
|
49
Vipshop
VIPS
$8.25B
| $275K | 0.45% |
+24,662
| New | +$275K |
|
|
KITE
50
DELISTED
Kite Pharma, Inc.
KITE
| $253K | 0.41% |
5,060
-482
| -9% | -$24.1K |
|